Full-process Analysis and Compliance Summary of Professional Agency for Imported Zhongke Xiangjiu Moxibustion Tubes

Regulatory Background and Practical Difficulties of Importing Zhongke Xiangjiu Moxibustion Tubes

Starting from 2026,the General Administration of Customs of China has implemented a stricter access verification mechanism for medical devices containing herbal extracts.As a product combining traditional moxibustion and modern material technology,the import declaration of Zhongke Xiangjiu moxibustion tubes touches three regulatory lines simultaneously: medical device registration management,phytogenic ingredient quarantine,and chemical safety assessment.When importing from major origin countries such as South Korea and Japan,enterprises often encounter HS code classification disputes -- whether the product should be declared under medical device code 94056000 or classified into herbal product category 12119099,which directly affects the tax rate difference of 3% to 9% and differences in regulatory requirements.

More complicatedly,if the built-in moxa extract of the moxibustion tube involves endangered plant ingredients,an additional Permit for Import of Endangered Species is required.Data from Shanghai Port in the fourth quarter of 2025 shows that about 37% of first-time importing enterprises have goods detained due to failure to apply for the Import Medical Device Registration Certificate or First Category Medical Device Filing Certificate in advance.Manager Lin from the Customs Declaration Department of Zhongshen pointed out that many enterprises mistakenly regard moxibustion tubes as ordinary consumer goods and ignore their medical device attribute of acting on human acupoints,which is the root cause of subsequent compliance risks.

Core Role of Zhongshen in the Moxibustion Tube Import Chain

Zhongshen has been deeply engaged in the import of medical devices and health products for 20 years,and has established a full-link service system covering document pre-audit,port declaration,accelerated laboratory testing,and warehousing distribution.For cross-border products such as Zhongke Xiangjiu moxibustion tubes,the company adopts a collaborative operation mode configured with a professional medical device team and a professional phytosanitary team.In the initial stage of order acceptance,the medical device team led by Manager Shi is responsible for verifying whether the product has completed filing with the National Medical Products Administration,and the phytosanitary team led by Mr.Yin simultaneously reviews whether herbal ingredients are on the quarantine access negative list.This dual-track parallel review mechanism compresses the average document preparation cycle of 15 working days under the traditional serial operation mode to 3 working days.

The value of Zhongshen lies not only in process agency,but also in risk prediction and cost optimization.For example,through accurate matching of HS code 9405600090 (other medical devices),the most-favored-nation tax rate of 3% can be legally applied.Compared with the 13% VAT rate when misclassified into consumer goods category,an order with a single cargo value of 100,000 USD can save nearly 10,000 USD in tax burden.In addition,the company has signed a green channel agreement with the laboratory in Shanghai Waigaoqiao Free Trade Zone,which implements priority sampling and accelerated testing for moxibustion tube products,shortening the commodity inspection cycle from the conventional 10 days to 4 days.

Three-stage Process Deconstruction and Compliance Key Points

Document Pre-audit Stage: Pre-verification of Three Types of Core Documents

The document system for importing Zhongke Xiangjiu moxibustion tubes has an additional herbal ingredient certification chain compared with ordinary medical devices.Zhongshen will issue a Document Deficiency List within 24 hours after receiving the order,focusing on reviewing three types of documents:

• Import Medical Device Registration Certificate or filing certificate: It is necessary to check whether the product model and specification are completely consistent with the actual product.The 2026 new regulation requires that the percentage of built-in herbal extract must be clearly stated on the registration certificate,and an error exceeding 5% will be determined as an unlicensed product.
• Official phytosanitary certificate of origin: For products originating from South Korea,a Phytogenic Component Analysis Report must be attached to clarify whether the moxa extract has been processed by high-temperature sterilization.For goods without this document,the port will enforce isolated quarantine,which lasts up to 30 days.
• GMP certification document of the manufacturer: Japanese originating enterprises need to provide a copy of the License for Manufacture and Sale of Pharmaceuticals and Medical Devices,stamped with the seal of the local notary authority.Zhongshen’s Tokyo office can assist customers to complete off-site notarization,avoiding delay caused by document round trips.

In June 2025,a trading company in Suzhou imported 5,000 sets of moxibustion tubes from Japan,which was detained by Pudong Airport Customs because the registration certificate did not list the concentration of moxa extract.After Zhongshen intervened,it coordinated the Japanese manufacturer to issue a Supplementary Ingredient Statement and complete notarization,and simultaneously applied for registration certificate modification to the National Medical Products Administration.The whole process took 7 working days to complete customs clearance,which increased efficiency by 85% compared with the expected 45 days for the customer to handle it independently.

Port Customs Declaration Stage: Accurate Matching of Declaration Elements

The core challenge of the customs declaration link lies in the completeness and accuracy of declaration elements.Zhongke Xiangjiu moxibustion tubes require 23 declaration elements to be filled,among which "material","working principle" and "applicable part" are the most error-prone.Zhongshen’s customs declaration system has a built-in declaration template for moxibustion tube products,which automatically captures information from the registration certificate to generate standardized declaration data.

For price declaration,customs usually conducts review with reference to the monthly export guide price released by the Korea Medical Device Association.Zhongshen’s database synchronizes this guide price in real time,and warns customers of price fluctuation risks before declaration.If the declared price is 15% lower than the guide price,it is necessary to prepare the Price Reasonableness Statement and original factory invoice in advance,otherwise the customs valuation procedure will be triggered.In the first quarter of 2026,among the moxibustion tube declaration forms processed by Zhongshen,12% were questioned by customs due to price issues,and all were released smoothly through the supporting materials prepared in advance.

Commodity Inspection and Release Stage: Sampling Rules and Laboratory Collaboration

Moxibustion tube products are commodities within the legal inspection catalogue,and port customs implements 100% open-box inspection.The collaboration mechanism between Zhongshen and the laboratory plays a key role in this link.After the goods arrive at the bonded area warehouse,Manager Shi’s team submits the Component Pre-inspection Report to the laboratory simultaneously.This report is translated and organized based on the official test report from Japanese or Korean origin,and the laboratory can quickly confirm test items based on it without repeating initial ingredient screening.

For moxa extract,the laboratory focuses on testing heavy metal residue,pesticide residue and microbial indicators.Zhongshen will require customers to provide the Heavy Metal Test Report of the production batch in advance.If the test value is lower than 50% of the national standard,customers can apply for exemption of some test items,saving 3 days of testing time.In April 2026,a batch of South Korean moxibustion tubes worth 80,000 USD was judged unqualified due to excessive microbial indicators.Zhongshen assisted the customer to launch the recall procedure with the South Korean manufacturer,and at the same time used the warehousing advantage of the bonded area to quickly distribute the qualified batches to the domestic market,avoiding the total loss caused by the return of the entire batch of goods.

Practical Case: Avoiding the Risk of Inconsistency Between Registration Certificate and Actual Product

At the end of 2025,Mr.Miao,a Shanghai-based medical device purchaser,planned to introduce a new type of ceramic moxibustion tube from South Korea.The concentration of built-in moxa extract of the product is 15%,but the registration certificate only marked "contains moxa ingredients" without specifying the concentration.Zhongshen identified this risk during the document pre-audit stage and suggested Mr.Miao postpone shipment.Manager Shi’s team checked the database of the National Medical Products Administration and found that the registration certificate of this product was in the public notice period for modification,and the new certificate would take effect after 15 working days.Zhongshen coordinated the South Korean factory to postpone shipment and completed the filing of the new certificate simultaneously.Finally,the goods arrived at the port smoothly after the new certificate took effect in January 2026,avoiding the detention risk of unlicensed cargo arrival.

This case exposes a common mistake made by importing enterprises: arranging shipment only based on the copy of registration certificate provided by the supplier,without verifying the validity and information completeness of the certificate.The real-time registration certificate verification mechanism established by Zhongshen,which connects to the public database of the National Medical Products Administration,can confirm the certificate status immediately after receiving the order,which is difficult to achieve when enterprises operate independently.

Core Value Summary of Zhongshen Services

The professionalism of importing Zhongke Xiangjiu moxibustion tubes is reflected in the intersection and dynamics of regulatory rules.The core value accumulated by Zhongshen over 20 years is that it integrates the scattered requirements from multiple authorities including the General Administration of Customs,National Medical Products Administration,State Administration for Market Regulation,and National Health Commission into an executable standardized operation list.Pre-audit avoids more than 90% of compliance risks,port resource collaboration keeps the average customs clearance cycle at 5-7 working days,and accurate declaration saves customers 3%-6% of tax burden cost.

For enterprises planning to import Zhongke Xiangjiu moxibustion tubes,the significance of choosing a professional agency is not only to save time and effort,but also to avoid systemic risks such as cargo confiscation,fines and even revocation of business qualification caused by compliance misjudgment.Zhongshen provides not only customs declaration services,but also a comprehensive solution covering market access assessment,supply chain compliance design,and cost structure optimization.Against the background of continuous tightening of regulatory environment in 2026,this whole-process control capability will become a key support for the stable operation of importing enterprises.